UBS Group’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-65
Closed 10558
2022
Q2
$0 Sell
65
-78
-55% ﹤0.01% 10450
2022
Q1
$1K Sell
143
-4,674
-97% -$32.7K ﹤0.01% 9079
2021
Q4
$27K Buy
4,817
+1,722
+56% +$9.65K ﹤0.01% 6413
2021
Q3
$34K Buy
3,095
+2,523
+441% +$27.7K ﹤0.01% 5540
2021
Q2
$9K Sell
572
-1,036
-64% -$16.3K ﹤0.01% 7096
2021
Q1
$43K Sell
1,608
-859
-35% -$23K ﹤0.01% 5701
2020
Q4
$89K Buy
2,467
+1,023
+71% +$36.9K ﹤0.01% 4776
2020
Q3
$51K Sell
1,444
-422
-23% -$14.9K ﹤0.01% 4792
2020
Q2
$80K Buy
1,866
+1,293
+226% +$55.4K ﹤0.01% 4661
2020
Q1
$46K Sell
573
-616
-52% -$49.5K ﹤0.01% 5019
2019
Q4
$110K Buy
1,189
+445
+60% +$41.2K ﹤0.01% 4926
2019
Q3
$57K Buy
744
+552
+288% +$42.3K ﹤0.01% 5196
2019
Q2
$19K Buy
192
+170
+773% +$16.8K ﹤0.01% 5793
2019
Q1
$1K Sell
22
-336
-94% -$15.3K ﹤0.01% 6764
2018
Q4
$22K Buy
358
+336
+1,527% +$20.6K ﹤0.01% 5802
2018
Q3
$1K Hold
22
﹤0.01% 6949
2018
Q2
$1K Hold
22
﹤0.01% 6933
2018
Q1
$2K Sell
22
-62
-74% -$5.64K ﹤0.01% 6680
2017
Q4
$15K Sell
84
-175
-68% -$31.3K ﹤0.01% 5806
2017
Q3
$11K Buy
259
+120
+86% +$5.1K ﹤0.01% 5939
2017
Q2
$7K Buy
139
+117
+532% +$5.89K ﹤0.01% 6053
2017
Q1
$3K Hold
22
﹤0.01% 6286
2016
Q4
$2K Sell
22
-48
-69% -$4.36K ﹤0.01% 6545
2016
Q3
$7K Sell
70
-78
-53% -$7.8K ﹤0.01% 6079
2016
Q2
$13K Buy
148
+126
+573% +$11.1K ﹤0.01% 5752
2016
Q1
$1K Hold
22
﹤0.01% 6591
2015
Q4
$3K Buy
22
+21
+2,100% +$2.86K ﹤0.01% 6503
2015
Q3
$1K Buy
+1
New +$1K ﹤0.01% 6731
2015
Q2
Sell
-18
Closed -$13K 6949
2015
Q1
$13K Buy
+18
New +$13K ﹤0.01% 5718